NeoGenomics Laboratories operates a network of cancer-focused testing laboratories, which is engaged in providing testing services to the pathologists, oncologists, urologists, hospitals, and other laboratories throughout the United States.
NeoGenomics' technology services include cytogenetics testing, which analyzes human chromosomes; fluorescence In-Situ Hybridization (FISH) testing, which analyzes abnormalities at the chromosomal and gene levels; flow cytometry testing, which analyzes gene expression of specific markers inside cells and on cell surfaces; immunohistochemistry testing, which analyzes the distribution of tumor antigens in specific cell and tissue types, and molecular testing which involves analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) to diagnose and predict the clinical significance of various genetic sequence disorders.
Specialties
Cytogenetics, Flow Cytometry, Fluorescence In Situ Hybridization (FISH), Molecular Genetics, Immunohistochemistry, Gene Expression Profile
New hires at NeoGenomics Laboratories
NeoGenomics Laboratories Activity on LinkedIn
-
NeoGenomics Laboratories has a new Laboratory Manager, Anatomic Pathology
Trent Coy is now Laboratory Manager, Anatomic Pathology
